Intra Cellular Therapies shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $387M | 5.3M | 73.17 |
| 2024-06-30 | $235M | 3.4M | 68.50 |
| 2024-03-31 | $122M | 1.8M | 69.20 |
| 2023-12-31 | $148M | 2.1M | 71.62 |
| 2023-09-30 | $108M | 2.1M | 52.09 |
| 2023-06-30 | $125M | 2.0M | 63.32 |
| 2023-03-31 | $95M | 1.7M | 55.56 |
| 2022-12-31 | $79M | 1.5M | 52.92 |
| 2022-06-30 | $11M | 189k | 56.96 |
| 2022-03-31 | $9.6M | 157k | 61.19 |
| 2021-12-31 | $7.4M | 141k | 52.34 |
| 2021-03-31 | $5.1M | 149k | 34.12 |
| 2020-12-31 | $5.1M | 160k | 31.80 |
| 2020-09-30 | $4.2M | 164k | 25.54 |
| 2020-06-30 | $4.3M | 166k | 25.67 |
| 2020-03-31 | $2.5M | 164k | 15.37 |
| 2019-12-31 | $13M | 379k | 34.31 |
| 2019-09-30 | $1.6M | 215k | 7.47 |
| 2019-06-30 | $2.7M | 211k | 12.70 |
| 2019-03-31 | $2.7M | 218k | 12.18 |
| 2018-12-31 | $2.8M | 249k | 11.39 |
| 2018-09-30 | $4.7M | 217k | 21.70 |
| 2018-06-30 | $4.5M | 257k | 17.66 |
| 2018-03-31 | $8.1M | 384k | 21.04 |
| 2017-12-31 | $7.5M | 517k | 14.48 |
| 2017-03-31 | $876k | 54k | 16.25 |
| 2016-12-31 | $1.4M | 96k | 15.08 |
| 2016-09-30 | $34k | 2.2k | 15.45 |
| 2016-06-30 | $5.7M | 146k | 38.82 |
| 2016-03-31 | $1.3M | 47k | 27.79 |
| 2015-12-31 | $1.9M | 36k | 53.80 |